Simplex Trading
ANTH

Simplex Trading’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Simplex Trading’s Portfolio ANTH Stock Details ANTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-352
Closed -$1K – 7199
2017
Q3 		$1K Sell
352
-36
-9% -$51 ﹤0.01% 5727
2017
Q2 		$3K Buy
388
+336
+646% +$753 ﹤0.01% 5129
2017
Q1 		$5K Buy
52
+26
+100% +$123 ﹤0.01% 4695
2016
Q4 		$1K Buy
26
+21
+420% +$363 ﹤0.01% 5671
2016
Q3 		$3K Sell
5
-3
-38% -$76 ﹤0.01% 4818
2016
Q2 		$2K Buy
+8
New +$226 ﹤0.01% 5115
2015
Q4 		– Sell
-10
Closed -$17K – 6587
2015
Q3 		$17K Sell
10
-19
-66% -$1.33K ﹤0.01% 2983
2015
Q2 		$75K Buy
29
+27
+1,350% +$1.25K 0.01% 1382
2015
Q1 		$2K Buy
+2
New +$59 ﹤0.01% 4276

Other funds holding ANTH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Simplex Trading's ANTH Position: Q1 2018 in Review

Simplex Trading sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q1 2018, closing a stake of 17 shares.

Simplex Trading first reported a position in ANTH in Q4 2014 and held it in 7 quarters. The position peaked at $28K in Q3 2016. 28 funds tracked by Wall St. Rank hold ANTH as of Q1 2018.

  • Simplex Trading reported no remaining Anthera Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Simplex Trading sold 17 Anthera Pharmaceuticals, Inc. shares in Q1 2018.
  • Simplex Trading first reported a position in Anthera Pharmaceuticals, Inc. in Q4 2014 and held it in 7 quarters.
  • Simplex Trading's Anthera Pharmaceuticals, Inc. position peaked at $28K in Q3 2016.
  • 28 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q1 2018.

Based on Simplex Trading's 13F filing for Q1 2018, filed 26 Apr 2018.